David Young
President & CEO at Processa Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Processa Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,531 | $1.93 | $4,885 |
| Jun 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,067 | $2.22 | $4,589 |
| May 29, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,786 | $2.57 | $4,590 |
| May 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,545 | $2.97 | $4,589 |
| Apr 30, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,706 | $2.69 | $4,589 |
| Apr 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,545 | $2.97 | $4,589 |
| Mar 31, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,810 | $2.54 | $4,597 |
| Jan 1, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +49 | — | — |
| Apr 1, 2025 | Processa Pharmaceuticals Inc. | Option exercise | +17,272 | — | — |
| Apr 1, 2025 | Processa Pharmaceuticals Inc. | Shares withheld for tax | −5,345 | $0.41 | $2,191 |
| Jan 27, 2025 | Processa Pharmaceuticals Inc. | Open-market purchase | +124,500 | $0.80 | $99,600 |
| Jul 10, 2024 | Processa Pharmaceuticals Inc. | Option exercise | +644 | — | — |
| Jul 10, 2024 | Processa Pharmaceuticals Inc. | Shares withheld for tax | −282 | $1.71 | $482 |
| Apr 5, 2024 | Processa Pharmaceuticals Inc. | Option exercise | +1,675 | — | — |
| Apr 5, 2024 | Processa Pharmaceuticals Inc. | Shares withheld for tax | −518 | $2.79 | $1,445 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.